Pregnancy does not incur greater risk of relapse for breast cancer survivors

NewsGuard 100/100 Score

A recent study published in the Journal of the National Cancer Institute indicates that pregnancy does not incur a greater risk of relapse for survivors of breast cancer. The safety of pregnancy for women with history of breast cancer has remained a controversial topic for many years, especially in cases of estrogen-receptor (ER) positive breast cancer. In these cases, hormones can promote the growth and spread of breast cancer so, as hormone levels change during pregnancy, it was thought that breast cancer would be more likely to recur in survivors of ER positive breast cancer during pregnancy.

The study compared breast cancer survivors who became pregnant with those who did not become pregnant over an average period of 7 years. The study tracked the recurrence rate of breast cancer and found that those who became pregnant did not experience a greater rate of recurrence, even in cases of ER positive breast cancer.

These findings show that pregnancy does not increase the risk of breast cancer recurrence, alleviating fears that pregnancy poses a greater risk to breast cancer survivors. The study notes that fears among physicians and patients may be a factor in the high rate of abortion among women who have a history of breast cancer.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NCCN 2024 Annual Conference focuses on practical applications for improving cancer care